Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | VEGF | 1088.5 | 66 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | VEGF | 929.0 | 37 | |
N2586 | JNK-IN-11 | 0.3 | uM | 1 | VEGF | 1057.0 | 55 | ||||
RA2159 | IGF-I | 100 | ug/mL | 1 | VEGF | 762.5 | 66 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 407.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 890.0 | 59 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 843.5 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 731.0 | 84 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 705.0 | 63 | |
RA2159 | 1 | VEGF | 706.0 | 56 | |||||||
N2586 | IGF-I | 100 | ug/mL | 1 | VEGF | 1258.0 | 64 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 1107.0 | 43 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 1179.5 | 62 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 1032.0 | 55 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 1026.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | VEGF | 1079.5 | 72 | |
N2586 | 1 | VEGF | 1134.5 | 100 | |||||||
RA2159 | Adiponectin | 5 | ng/mL | 1 | VEGF | 562.0 | 53 | ||||
RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 367.5 | 70 | |
RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 486.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 634.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 486.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 329.0 | 75 | |
N2586 | Adiponectin | 5 | ng/mL | 1 | VEGF | 492.0 | 45 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | VEGF | 783.0 | 59 |